CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Oct. 31, 2015	Jul. 31, 2015
Current Assets:
Cash and cash equivalents	$ 52,428	$ 749,965
Other current assets	51,962	51,240
Total Current Assets	104,391	801,205
Property and Equipment, Net	2,459	2,869
Patents, Net	1,377,451	1,430,016
TOTAL ASSETS	1,484,301	2,234,090
Current Liabilities:
Accounts payable and accrued expenses (Note 4)	8,538,585	8,018,833
Total Current Liabilities	8,538,585	8,018,833
Derivative Warrant Liability (Note 7 and 8)	2,525,315	2,363,415
Derivative Additional Investment Rights Liability (Note 7 and 8)	296,725	142,662
Total Liabilities	$ 11,360,625	$ 10,524,410
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 2,450,000,000 and 1,500,000,000 shares at October 31, 2015 and July 31, 2015, respectively; 870,325,348 and 825,496,238 issued and outstanding at October 31, 2015 and July 31, 2015, respectively	$ 45,010	$ 825,496
Additional paid-in capital	362,660,077	362,556,710
Accumulated deficit	(374,212,528)	(372,481,263)
Accumulated other comprehensive income	805,802	808,737
Total Stockholders' Deficiency	(9,876,324)	(8,290,320)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$ 1,484,301	$ 2,234,090
Series A Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series B Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series C Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series D Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series E Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series F Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series G Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock